| For: | Sun H, Ren J, Zhu Q, Kong FZ, Wu L, Pan BR. Effects of lysophosphatidic acid on human colon cancer cells and its mechanisms of action. World J Gastroenterol 2009; 15(36): 4547-4555 [PMID: 19777613 DOI: 10.3748/wjg.15.4547] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i36/4547.htm |
| Number | Citing Articles |
| 1 |
M. Cristina Castañeda-Patlán, Juan Carlos Martínez- Morales, Marco Antonio Morquecho-León, Paola Briseño-Díaz, K. Helivier Solís, M. Teresa Romero-Ávila, J. Adolfo García-Sáinz, Martha Robles-Flores. The LPA2 receptor PDZ domain affects canonical Wnt signaling in colon cancer cells. Cellular Signalling 2026; 139 doi: 10.1016/j.cellsig.2025.112318
|
| 2 |
Xiusheng Zhu, Lanyu Li, Bangjun Gao, Dandan Zhang, Yanyan Ren, Beibei Zheng, Mengmei Li, Deshun Shi, Ben Huang. Early development of porcine parthenogenetic embryos and reduced expression of primed pluripotent marker genes under the effect of lysophosphatidic acid. Reproduction in Domestic Animals 2018; 53(5) doi: 10.1111/rda.13226
|
| 3 |
Si Liu, Haiyan Jiang, Li Min, Tingting Ning, Junxuan Xu, Tiange Wang, Xingyu Wang, Qian Zhang, Ruizhen Cao, Shutian Zhang, Shengtao Zhu. Lysophosphatidic acid mediated PI3K/Akt activation contributed to esophageal squamous cell cancer progression. Carcinogenesis 2021; 42(4) doi: 10.1093/carcin/bgaa143
|
| 4 |
Renata de Freitas Saito, Luciana Nogueira de Sousa Andrade, Silvina Odete Bustos, Roger Chammas. Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.768606
|
| 5 |
Metabolomic analysis and identification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipids. Journal of Lipid Research 2012; 53(8) doi: 10.1194/jlr.M027185
|
| 6 |
Gizem E. Genc, Victoria E.B. Hipolito, Roberto J. Botelho, Saadet Gumuslu. Lysophosphatidic acid represses autophagy in prostate carcinoma cells. Biochemistry and Cell Biology 2019; 97(4) doi: 10.1139/bcb-2018-0164
|
| 7 |
|
| 8 |
Matteo Centonze, Giusy Di Conza, Michael Lahn, Isabel Fabregat, Francesco Dituri, Isabella Gigante, Grazia Serino, Rosanna Scialpi, Livianna Carrieri, Roberto Negro, Elena Pizzuto, Gianluigi Giannelli. Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models. Journal of Experimental & Clinical Cancer Research 2023; 42(1) doi: 10.1186/s13046-023-02780-4
|
| 9 |
Daphna Mokady, David Meiri. RhoGTPases – A novel link between cytoskeleton organization and cisplatin resistance. Drug Resistance Updates 2015; 19 doi: 10.1016/j.drup.2015.01.001
|
| 10 |
Nasser Samadi, Raie Bekele, Dora Capatos, Ganesh Venkatraman, Meltem Sariahmetoglu, David N. Brindley. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance. Biochimie 2011; 93(1) doi: 10.1016/j.biochi.2010.08.002
|
| 11 |
Ji-yuan Sun. GPCR-CARMA3-NF-kappaB signaling axis: A novel drug target for cancer therapy. Clinical Oncology and Cancer Research 2010; 7(3) doi: 10.1007/s11805-010-0512-1
|
| 12 |
Derya Isler, Mehmet Ozaslan, Isik Didem Karagoz, Ibrahim Halil Kilic, Metin Karakok, Seyithan Taysi, Izzettin Guler, Ahmet Cakmak, Abdullah Tuncay Demiryurek. Antitumoral effect of a selective Rho-kinase inhibitor Y-27632 against Ehrlich ascites carcinoma in mice. Pharmacological Reports 2014; 66(1) doi: 10.1016/j.pharep.2013.06.006
|
| 13 |
A. Kuksis, Y. Itabashi, W. Pruzanski. Encyclopedia of Lipidomics. 2016; doi: 10.1007/978-94-007-7864-1_163-1
|
| 14 |
Donghee Kim, Hyo-Jin Kim, Jin-Ok Baek, Joo-Young Roh, Hee-Sook Jun. Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway. International Journal of Molecular Sciences 2021; 22(19) doi: 10.3390/ijms221910777
|
| 15 |
Mariana Ramos Gonzaga, Sofia Xavier Silva, Giovana Diniz Jorge, Alessandro Furtado Silva. Ácido Lisofosfatídico: alvo promissor para novas terapêuticas no Câncer Colorretal. Cuadernos de Educación y Desarrollo 2024; 16(12 Edição Especial) doi: 10.55905/cuadv16n12-063
|
| 16 |
Dongjun Lee, Dong-Soo Suh, Sue Chin Lee, Gabor J. Tigyi, Jae Ho Kim. Role of autotaxin in cancer stem cells. Cancer and Metastasis Reviews 2018; 37(2-3) doi: 10.1007/s10555-018-9745-x
|
| 17 |
Ingun Heiene Tveteraas, Monica Aasrum, Ingvild Johnsen Brusevold, John Ødegård, Thoralf Christoffersen, Dagny Sandnes. Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cells. Tumor Biology 2016; 37(2) doi: 10.1007/s13277-015-4010-1
|
| 18 |
Ming Quan, Jiu-jie Cui, Xiao Feng, Qian Huang. The critical role and potential target of the autotaxin/lysophosphatidate axis in pancreatic cancer. Tumor Biology 2017; 39(3) doi: 10.1177/1010428317694544
|
| 19 |
Yan Liao, Ganggang Mu, Lingli Zhang, Wei Zhou, Jun Zhang, Honggang Yu. Lysophosphatidic Acid Stimulates Activation of Focal Adhesion Kinase and Paxillin and Promotes Cell Motility, via LPA1–3, in Human Pancreatic Cancer. Digestive Diseases and Sciences 2013; 58(12) doi: 10.1007/s10620-013-2878-4
|
| 20 |
Ondřej Vít, Jiří Petrák. Autotaxin and Lysophosphatidic Acid Signalling: the Pleiotropic Regulatory Network in Cancer. Folia Biologica 2023; 69(5-6) doi: 10.14712/fb2023069050149
|
| 21 |
Xiaoyun Tang, Matthew G.K. Benesch, David N. Brindley. Role of the autotaxin–lysophosphatidate axis in the development of resistance to cancer therapy. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(8) doi: 10.1016/j.bbalip.2020.158716
|
| 22 |
Nan Sethakorn, Nickolai O. Dulin. RGS expression in cancer: oncomining the cancer microarray data. Journal of Receptors and Signal Transduction 2013; 33(3) doi: 10.3109/10799893.2013.773450
|
| 23 |
Fernanda Leve, Taline Guimarães Corrêa Marcondes, Lilian Gonçalves R. Bastos, Sarah Vieira Rabello, Marcelo Neves Tanaka, José Andrés Morgado-Díaz. Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA–Rock and Src–FAK signalling in colon cancer cells. European Journal of Pharmacology 2011; 671(1-3) doi: 10.1016/j.ejphar.2011.09.006
|
| 24 |
Tamotsu Tsukahara, Kimiko Murakami-Murofushi. Release of Cyclic Phosphatidic Acid from Gelatin-based Hydrogels Inhibit Colon Cancer Cell Growth and Migration. Scientific Reports 2012; 2(1) doi: 10.1038/srep00687
|
| 25 |
Lianqing Lou, Yong Xin Chen, Lingzhen Jin, Xiaofei Li, Xingfei Tao, Jinhong Zhu, Xiangyi Chen, Shuang Wu, Weiwei Ye, Jinke He, Guoqiang Ding. Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor. Journal of International Medical Research 2013; 41(1) doi: 10.1177/0300060512474124
|
| 26 |
Jiyuan Sun. CARMA3: A novel scaffold protein in regulation of NF-κB activation and diseases. World Journal of Biological Chemistry 2010; 1(12): 353-361 doi: 10.4331/wjbc.v1.i12.353
|
| 27 |
Silvia Anahi Valdés-Rives, Aliesha González-Arenas. Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development. Mediators of Inflammation 2017; 2017 doi: 10.1155/2017/9173090
|
| 28 |
Anna Jesionowska, Elzbieta Cecerska-Heryc, Natalia Matoszka, Barbara Dolegowska. Lysophosphatidic acid signaling in ovarian cancer. Journal of Receptors and Signal Transduction 2015; 35(6) doi: 10.3109/10799893.2015.1026444
|